Table V.
Multivariate analysis of factors associated with reporting of side-effects following booster dose of Pfizer-BioNTech (BNT162b2) vaccine among the participants (n = 370)
Variable | aOR | 95% CI | P-value |
---|---|---|---|
Gender (female) | 2.286 | 0.803, 6.508 | 0.121 |
History of comorbidities | 3.434 | 1.116, 10.569 | 0.031∗ |
History of COVID-19 infection | 1.860 | 0.642, 5.384 | 0.253 |